Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity

Nature Communications

Volumn 5, Issue , 2014, Pages

  Vogl, Thomas ^a   Eisenblätter, Michel ^a,b   Völler, Tom ^a   Zenker, Stefanie ^a   Hermann, Sven ^a   Van Lent, Peter ^c   Faust, Andreas ^a   Geyer, Christiane ^a   Petersen, Beatrix ^a   Roebrock, Kirsten ^a   Schäfers, Michael ^a   Bremer, Christoph ^a,d   Roth, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; BIOLOGICAL MARKER; CARBOCYANINE; COLLAGEN; CY5.5 CYANINE DYE; FLUORINE; S100A8 PROTEIN, MOUSE; S100A9 PROTEIN, MOUSE;

BIOMARKER; GENETIC MARKER; IMAGING METHOD; MOLECULAR ANALYSIS; PATHOGENICITY;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; INFLAMMATION; INNATE IMMUNITY; LEISHMANIASIS; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SKIN ALLERGY; TH1 CELL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CONTACT DERMATITIS; CYTOLOGY; FEMALE; HYPERSENSITIVITY; MALE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; SKIN LEISHMANIASIS;

ANIMALS; ARTHRITIS; BIOMARKERS; CALGRANULIN A; CALGRANULIN B; CARBOCYANINES; COLLAGEN; DERMATITIS, CONTACT; FEMALE; FLUORINE RADIOISOTOPES; HYPERSENSITIVITY; INFLAMMATION; LEISHMANIASIS, CUTANEOUS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR IMAGING; PHAGOCYTES; POSITRON-EMISSION TOMOGRAPHY; TH1 CELLS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84907346339     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5593     Document Type: Article

References (44)

1. Chan, A. C. & Behrens, T. W. Personalizing medicine for autoimmune and inflammatory diseases. Nat. Immunol. 14, 106-109 (2013).
2. Gotthardt, M., Bleeker-Rovers, C. P., Boerman, O. C. & Oyen, W. J. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J. Nucl. Med. 51, 1937-1949 (2010).
3. Chan, J. K. et al. Alarmins: awaiting a clinical response. J. Clin. Invest. 122, 2711-2719 (2012).
4. Harris, H. E., Andersson, U. & Pisetsky, D. S. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol 8, 195-202 (2012).
5. Rock, K. L., Latz, E., Ontiveros, F. & Kono, H. The sterile inflammatory response. Annu. Rev. Immunol. 28, 321-342 (2010).
6. Yang, D., de la Rosa, G., Tewary, P. & Oppenheim, J. J. Alarmins link neutrophils and dendritic cells. Trends Immunol. 30, 531-537 (2009).
7. Ehrchen, J. M., Sunderkotter, C., Foell, D., Vogl, T. & Roth, J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 86, 557-566 (2009).
8. Vogl, T. et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042-1049 (2007). (Pubitemid 47517513)
9. Loser, K. et al. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat. Med. 16, 713-717 (2010).
10. van Lent, P. L. et al. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann. Rheum. Dis. 67, 1750-1758 (2008).
11. van Lent, P. L. et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum. 64, 1466-1476 (2012).
12. Foell, D. et al. Methotrexate withdrawal at 6 vs. 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 303, 1266-1273 (2010).
13. Petersen, B. et al. The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis. EMBO J. 32, 100-111 (2013).
14. Haroon, A., Zumla, A. & Bomanji, J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin. Infect. Dis. 54, 1333-1341 (2012).
15. Frosch, M. et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43, 628-637 (2000). (Pubitemid 30394955)
16. Sacks, D. & Noben-Trauth, N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858 (2002). (Pubitemid 37328707)
17. McDonald, B. et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330, 362-366 (2010).
18. van Zoelen, M. A. et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am. J. Respir. Crit. Care Med. 180, 1098-1106 (2009).
19. Huckins, D. S. et al. A novel biomarker panel to rule out acute appendicitis in pediatric patients with abdominal pain. Am. J. Emerg. Med. 31, 1368-1375 (2013).
20. Barrera, P. et al. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Rheumatology 39, 870-874 (2000). (Pubitemid 30649513)
21. Barrera, P., Oyen, W. J., Boerman, O. C. & van Riel, P. L. Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis. Ann. Rheum. Dis. 62, 825-828 (2003). (Pubitemid 37026491)
22. Roimicher, L. et al. (99m)Tc-anti-TNF-alpha scintigraphy in RA: a comparison pilot study with MRI and clinical examination. Rheumatology (Oxford) 50, 2044-2050 (2011).
23. Achouiti, A. et al. Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis. PLoS Pathog. 8, e1002987 (2012).
24. Rammes, A. et al. Myeloid-related protein (MRP) 8 and MRP14, calciumbinding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 272, 9496-9502 (1997). (Pubitemid 27154966)
25. Robinson, M. J., Tessier, P., Poulsom, R. & Hogg, N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem. 277, 3658-3665 (2002). (Pubitemid 34953239)
26. Teigelkamp, S. et al. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J. Biol. Chem. 266, 13462-13467 (1991). (Pubitemid 21907367)
27. Maiseyeu, A. et al. In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles. Arterioscler. Thromb. Vasc. Biol. 32, 962-970 (2012).
28. Cesaro, A. et al. An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis. PLoS ONE 7, 18 (2012).
29. Gompels, L. L. et al. In vivo fluorescence imaging of E-selectin: quantitative detection of endothelial activation in a mouse model of arthritis. Arthritis Rheum. 63, 107-117 (2011).
30. Viemann, D. et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105, 2955-2962 (2005). (Pubitemid 40446292)
31. Gaal, J. et al. 99m Tc-HMPAO labelled leukocyte scintigraphy in patients with rheumatoid arthritis: a comparison with disease activity. Nucl. Med. Commun. 23, 39-46 (2002). (Pubitemid 34214305)
32. Mountz, J. M., Alavi, A. & Mountz, J. D. Emerging optical and nuclear medicine imaging methods in rheumatoid arthritis. Nat. Rev. Rheumatol. 8, 719-728 (2012).
33. Gross, S. et al. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat. Med. 15, 455-461 (2009).
34. Ntziachristos, V., Ripoll, J., Wang, L. V. & Weissleder, R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol. 23, 313-320 (2005). (Pubitemid 41094419)
35. Peterson, J. D. et al. Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis. Arthritis Res. Ther. 12, R105 (2010).
36. de la Rosa, X. et al. In vivo imaging of induction of heat-shock protein-70 gene expression with fluorescence reflectance imaging and intravital confocal microscopy following brain ischaemia in reporter mice. Eur. J. Nucl. Med. Mol. Imaging 40, 426-438 (2013).
37. Kim, S. Y. & Myung, S. J. Optical molecular imaging for diagnosing intestinal diseases. Clin. Endosc. 46, 620-626 (2013).
38. Leach, S. T. & Day, A. S. S100 proteins in the pathogenesis and diagnosis of inflammatory bowel disease. Expert Rev. Clin. Immunol. 2, 471-480 (2006). (Pubitemid 44355577)
39. Werner, S. G. et al. Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology. Ann. Rheum. Dis. 71, 504-510 (2012).
40. Hiratsuka, S. et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349-1355 (2008).
41. Orosco, R. K., Tsien, R. Y. & Nguyen, Q. T. Fluorescence imaging in surgery. IEEE Rev. Biomed. Eng. 6, 178-187 (2013).
42. Huang, C. H. & Tsourkas, A. Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging. Curr. Top. Med. Chem. 13, 411-421 (2013).
43. Manitz, M. P. et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell Biol. 23, 1034-1043 (2003).
44. Koenders, M. I. et al. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1beta, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis. Arthritis Rheum. 63, 2329-2339 (2011).